Clinical Trials Logo
  1. Home
  2. Ataxia Telangiectasia
  3. NCT05471310

Videoocular Assessment of Eye Movement Activity in an Ataxia Telangiectasia

Ataxia Telangiectasia Clinical Trial

Official title:
Eye-tacking Method as a Diagnostic Tool for Assessment of Oculomotor Parameters (Gaze-holding Score, Scan Path, Visually Guided Saccades Etc) in Pediatric Patients With Ataxia Telangiectasia

Clinical Trial Summary

Ataxia-telangiectasia (A-T) is a multisystem auto-somal recessive disorder linked to the A-T mutated gene (ATM) on chromosome 11q22-23, and characterized by progressive neural degeneration, immunodeficiency, and progressive ocular motor dysfunction. In previous studies, the quantitative description of the ocular motor deficits from clinical examination was limited to various defects in saccade and gaze control, dysmetric saccades, impairments of smooth pursuit, gaze holding, convergence, vestibular and optokinetic nystagmus slow phases, and cancellation of the vestibulo-ocular reflex. The aim of our research is to add existing findings with quantitative description of oculomotor patterns in A-T patients using videooculography (VOG).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05471310
Study type Observational
Source Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Contact
Status Completed
Phase
Start date March 15, 2021
Completion date June 30, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT02345135 - Susceptibility to Infections in Ataxia Telangiectasia N/A
Active, not recruiting NCT04991701 - A National Retrospective Population Based Cohort Study of the Natural History of Ataxia Telangiectasia
Active, not recruiting NCT05531890 - Comparative Bioavailability of Betamethasone Oral Solution Metered Spray (GTX-102) in Healthy Subjects Phase 1
Recruiting NCT05692596 - The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
Completed NCT05252819 - Whole Body MRI for Cancer Surveillance in A-T
Recruiting NCT03357978 - Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia N/A
Withdrawn NCT02309632 - Pancreatic Cancer Screening of High-Risk Individuals in Arkansas N/A
Not yet recruiting NCT06324877 - Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside N/A
Not yet recruiting NCT01075438 - Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients N/A
Completed NCT03962114 - Effects of Vitamin B3 in Patients With Ataxia Telangiectasia Phase 2
Completed NCT04513002 - Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis Phase 2
Active, not recruiting NCT04870866 - NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia Phase 2
Recruiting NCT03563053 - Open-label, Long-term, Extension Treatment Using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients With Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study Phase 3
Recruiting NCT05692622 - Home-based Complex Intervention for Children With Ataxia Telangiectasia N/A
Recruiting NCT04037189 - Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia
Not yet recruiting NCT04887311 - MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia Phase 2
Active, not recruiting NCT00951886 - The Validity of Forced Expiratory Maneuvers in Ataxia Telangiectasia Studied Longitudinally N/A
Recruiting NCT03759678 - N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T) Phase 2
Recruiting NCT01052623 - Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT) Phase 4
Enrolling by invitation NCT04605523 - Neurofilament Light- Chain in Ataxia Telangiectasia